Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study

Pediatrics

Volumn 124, Issue 1, 2009, Pages 71-78

  Biederman, Joseph ^a   Monuteaux, Michael C ^a   Spencer, Thomas ^a   Wilens, Timothy E ^a   Faraone, Stephen V ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

ADHD; Comorbidity; Psychopharmacology; Stimulants

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; PEMOLINE;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CASE CONTROL STUDY; CHILD; CLINICAL ASSESSMENT; COMORBIDITY; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DEPRESSION; DISRUPTIVE BEHAVIOR; FOLLOW UP; HUMAN; LONG TERM MEMORY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROPROTECTION; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMORBIDITY; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; PROPORTIONAL HAZARDS MODELS;

EID: 67649632083     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-3347     Document Type: Article

References (41)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003;2(2):104-113
3. Mannuzza S, Klein RG, Bessler A, Malloy P, Hynes ME. Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1222-1227 (Pubitemid 27381278)
4. Mannuzza S, Klein R, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry. 1998;155(4):493-498 (Pubitemid 28207444)
5. Biederman J, Mick E, Faraone SV, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002;159(1):36-42 (Pubitemid 41070724)
6. Biederman J, Monuteaux M, Mick E, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10 year prospective follow-up study. Psychol Med. 2006;36(2):167-179 (Pubitemid 43126141)
7. Biederman J, Faraone S, Milberger S, et al. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry. 1996;53(5):437-446 (Pubitemid 26149233)
8. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993;50(7):565-576 (Pubitemid 23203567)
9. Barkley RA, Anastopoulos AD, Guevremont DC, Fletcher KE. Adolescents with ADHD: patterns of behavioral adjustment, academic functioning, and treatment utilization. J Am Acad Child Adolesc Psychiatry. 1991;30(5):752-761
10. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-921
11. Faraone SV, Biederman J, Spencer TJ, Aleardi M. Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed. 2006;8(4):4 (Pubitemid 44541837)
12. Daviss WB, Birmaher B, Diler RS, Mintz J. Does pharmacotherapy for attention-deficit/hyperactivity disorder predict risk of later major depression? J Child Adolesc Psychopharmacol. 2008;18(3):257-264
13. Angold A, Costello J, Erkanli A. Comorbidity. J Child Psychol Psychiatry. 1999;40(1):57-87
14. Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry. 1998;59(suppl 7):50-58 (Pubitemid 28317222)
15. Bolaños CA, Barrot M, Berton O, Wallace-Black D, Nestler E. Methylphenidate treatment during preand periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry. 2003;54(12):1317-1329 (Pubitemid 37522155)
16. Carlezon WA Jr, Mague SD, Andersen SL. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry. 2003;54(12):1330- 1337 (Pubitemid 37522156)
17. Sinzig J, Dopfner M, Lehmkuhl G, et al. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007;17(4):421-432 (Pubitemid 47422214)
18. Klein R, Abikoff H, Klass E, Gameles D, Seese L, Pollack S. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry. 1997;54(12):1073-1080 (Pubitemid 27524371)
19. Connor DF, Barkley RA, Davis HT. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr (Phila). 2000;39(1):15-25 (Pubitemid 30044196)
20. Scheffer RE, Niskala Apps JA. The diagnosis of preschool bipolar disorder presenting with mania: open pharmacological treatment. J Affect Disord. 2004;82(suppl 1):S25-S34 (Pubitemid 39574981)
21. Carlson PJ, Merlock MC, Suppes T. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. Bipolar Disord. 2004;6(5):416-420 (Pubitemid 39345293)
22. Lydon E, El-Mallakh RS. Naturalistic long-term use of methylphenidate in bipolar disorder. J Clin Psychopharmacol. 2006;26(5):516-518 (Pubitemid 44401475)
23. Scheffer RE, Kowatch RA, Carmody T, Rush AJ. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry. 2005;162(1):58-64 (Pubitemid 40095673)
24. Biederman J, Mick E, Prince J, et al. Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. J Child Adolesc Psychopharmacol. 1999;9(4):247-256 (Pubitemid 30005079)
25. Biederman J, Mick E, Spencer TJ, Wilens TE, Faraone SV. Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol. 2000;10(3):185-192 (Pubitemid 30768684)
26. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schwartz J. Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder. J Clin Psychopharmacol. 2002;22(3):267-274 (Pubitemid 34546842)
27. DuPaul GJ, Barkley RA, McMurray MB. Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry. 1994;33(6):894-903 (Pubitemid 24196914)
28. Powers RL, Marks DJ, Miller CJ, Newcorn JH, Halperin JM. Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. J Child Adolesc Psychopharmacol. 2008;18(5):449-459
29. Hechtman L, Abikoff H, Klein RG, et al. Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004;43(7):812-819 (Pubitemid 38808486)
30. Raggi VL, Chronis AM. Interventions to address the academic impairment of children and adolescents with ADHD. Clin Child Fam Psychol Rev. 2006;9(2):85-111 (Pubitemid 44825038)
31. Biederman J, Faraone SV, Keenan K, et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry. 1992;49(9):728-738
32. Busch B, Biederman J, Cohen L, et al. Similar correlates of ADHD in children from pediatric and psychiatric clinics. Psychiatr Serv. 2002;53(9):1103-1111 (Pubitemid 34976621)
33. Faraone SV, Tsuang MT, Tsuang D. Genetics and Mental Disorders: A Guide for Students, Clinicians, and Researchers. New York, NY: Guilford Press; 1999
34. Faraone S, Tsuang M. Measuring diagnostic accuracy in the absence of a "gold standard." Am J Psychiatry. 1994;151(5):650-657
35. Orvaschel H. Schedule for Affective Disorder and Schizophrenia for School-age Children, Epidemiologic Version. 5th ed. Ft. Lauderdale, FL: Nova Southeastern University, Center for Psychological Studies; 1994
36. Spitzer RL, Williams JB, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R: Non-patient Edition (SCID-NP, Version 1.0). Washington, DC: American Psychiatric Press; 1990
37. Hollingshead AB. Four Factor Index of Social Status. New Haven, CT: Yale Press; 1975
38. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008;165(5):597-603 (Pubitemid 351705336)
39. Molina BS, Flory K, Hinshaw SP, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry. 2007;46(8):1028-1040 (Pubitemid 47220685)
40. Swanson JM, Hinshaw SP, Arnold LE, et al. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry. 2007;46(8):1003-1014 (Pubitemid 47220684)
41. Biederman J, Faraone SV, Weber W, Russell RL, Rater M, Park K. Correspondence between DSM-III-R and DSM-IV attention deficit hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry. 1997;36(12):1682-1687 (Pubitemid 27512322)